Monash University Department of Physiology Clayton, VIC, Australia
Michael Cowley, PhD, is the founding director of the Monash Obesity & Diabetes Institute and Professor of Physiology at Monash University. He is also director of an Australian diabetes drug development company, Verva Inc., and founder of Orexigen Therapeutics, a San Diego biotech company where he served as the Chief Scientific Officer until December 2008.
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com. We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser window will open and remain open until you have completed your visit to this website.